XML 32 R13.htm IDEA: XBRL DOCUMENT v3.19.2
Preferred Stock and Common Stock Warrants
6 Months Ended
Jun. 30, 2019
Preferred Stock and Common Stock Warrants  
Preferred Stock and Common Stock Warrants

Note 7 – Preferred Stock and Common Stock Warrants

Preferred Stock

In August 2018, we sold an aggregate of 50,000 shares of Series A Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock), at $1,000 per share for an aggregate purchase price of $50 million and we issued an additional 1,000 shares of Series A Preferred Stock in aggregate as origination fees to the purchasers of the Series A Preferred Stock.  In September 2018 and May 2019, we sold an aggregate of 29,055 shares and 20,945 shares, respectively, of Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock” and, together with the Series A Preferred Stock, the “Convertible Preferred Stock”), at $1,000 per share for a combined purchase price of $50 million and we issued an additional 999 shares of Series B Preferred Stock in aggregate as origination fees to the purchasers of the Series B Preferred Stock. Warrants were issued together with the shares of Convertible Preferred Stock (“Common Stock Warrants”).

The shares of Convertible Preferred Stock bear dividends at a rate of 12% per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value.  Such dividends are payable quarterly and may be paid in cash or in-kind.  During the six months ended June 30, 2019, the Company paid-in-kind $3.1 million and $1.8 million of dividends to the holders of the Series A Preferred Stock and the Series B Preferred Stock, respectively.  On July 15, 2019, the Company paid-in-kind $1.6 million and $1.2 million of dividends to the holders of the Series A Preferred Stock and the Series B Preferred Stock, respectively, as of the close of business on June 15, 2019.

Common Stock Warrants

Pursuant to ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, the fair value of the Common Stock Warrants was recorded as a non-current liability on our Consolidated Balance Sheet on the issuance dates.  The Company revalues the Common Stock Warrants at each balance sheet date and recognized a loss of $1.6 million and $1.8 million during the three and six months ended June 30, 2019, respectively. The Common Stock Warrants are included in Level 3 of the fair value hierarchy.

The Common Stock Warrants have a fixed three-year term commencing on the closings of the issuances of the associated Convertible Preferred Stock.  The Common Stock Warrants may only be exercised by the holders thereof at the expiration of such three-year term; however, the Company can force exercise of the Common Stock Warrants prior to expiration of such term if the volume weighted average trading price of shares of Company common stock for each trading day during any 60 of the prior 90 trading days is equal to or greater than 175% of the Conversion Price (as defined in the certificate of designations of the applicable Convertible Preferred Stock) and, in the case of the warrants issued together with the Series B Preferred Stock (the “Series B Warrants”), also if the Company simultaneously elects to force a mandatory exercise of all other warrants then outstanding and unexercised and held by any holder of parity stock. 

The Company used a Monte Carlo simulation model to estimate the fair value of the Common Stock Warrants using the following assumptions:

 

 

 

 

 

 

 

 

 

June 30, 

 

December 31, 

 

 

2019

 

2018

Stock price

 

$

6.32

 

$

5.40

Exercise price

 

$

0.01

 

$

0.01

Risk-free rate

 

 

1.8%

 

 

2.5%

Volatility

 

 

27.6%

 

 

33.1%

Term (years)

 

 

2.4

 

 

2.7

 

Beneficial Conversion Feature

ASC 470-20-20 – Debt – Debt with conversion and Other Options (“ASC 470-20”) defines a beneficial conversion feature (“BCF”) as a nondetachable conversion feature that is in the money at the issuance date.  The Company was required by ASC 470-20 to allocate a portion of the proceeds from the Series A Preferred Stock equal to the intrinsic value of the BCF to additional paid-in capital. We are recording the accretion of the $2.5 million Series A Preferred Stock discount attributable to the BCF as a deemed dividend using the effective yield method over the period prior to the expected conversion date. Deemed dividends on the Series A Preferred Stock was $0.5 million and zero during the three months ended June 30, 2019 and 2018, respectively, and $1.0 million and zero during the six months ended June 30, 2019 and 2018, respectively.

Initial Fair Value Allocation

Net cash proceeds from the sale of the Series B Preferred Stock in May 2019 were allocated on a fair value basis to the Series B Warrants and on a relative fair value basis to the Series B Preferred Stock.

The allocation of the net cash proceeds is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of Proceeds

 

 

 

 

 

 

 

 

Series B

 

 

 

 

 

Series B

 

Preferred

 

    

 

 

    

Warrants

    

Stock

Gross proceeds

 

$

20,945

 

 

 

 

 

 

Equity issuance costs

 

 

 —

 

 

 

 

 

 

Net proceeds - Initial Fair Value Allocation

 

$

20,945

 

$

1,936

 

$

19,009

Per balance sheet upon issuance

 

 

 

 

$

1,936

 

$

19,009